Anticoagulant Use In Hospice

Anticoagulant Use In Hospice 

This module is designed to improve awareness of the benefits and risks of both continuing and discontinuing anticoagulant therapy and regular reassessment to make an informed and balanced decision based on patient goals of care.

$0.00

Hours: 0.70 - 0.75
PSCC-ANTICO-ENCLARA

Certificates

Certificates provided by accrediting body (4 Match)

District of Columbia Board of Nursing

0.7 HOURS


DC-RN -- District of Columbia Board of Nursing Approved Continuing Education program (CE Provider #50-290).

Nurses will receive 0.70 contact hours for participating in this course.

American Nurses Credentialing Center

0.75 HOURS


Relias, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses will receive 0.75 contact hours for participating in this course.

Georgia Board of Nursing

0.75 HOURS


Georgia Board of Nursing CE Provider #: 50-290

Nurses will receive 0.75 contact hours for participating in this course.

South Carolina Board of Nursing

0.75 HOURS


This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CE provider #50-290) CE Broker Course # 20-[Custom_Code]

Course Details

Course Code: PSCC-ANTICO-ENCLARA
Hours: 0.75
Type: Online Course
Content Expiration Date: 9/30/2021
Learning Objectives:
Recognize the risk factors of venous thromboembolism (VTE) in patients with and without cancer
Assess risk of anticoagulant-induced adverse drug event (ADE) based on patient-specific factors
Evaluate benefits and risks of both continuing and discontinuing anticoagulant therapy to make a balanced decision based on patient goals of care

Outline:

Recognize the risk factors of venous thromboembolism (VTE) in patients with and without cancer



- VTE risk factors (patients without cancer)



- VTE risk factors (patients with cancer)



- Incidence of VTE



- Hospice patients and evidence



Assess risk of anticoagulant-induced adverse drug event (ADE) based on patient-specific factors



- Anticoagulant agents



- Indications



- Duration of use



- Risk factors for bleeding



- Benefits of use



- Cost and other product considerations



Evaluate benefits and risks of both continuing and discontinuing anticoagulant therapy to make a balanced decision based on patient goals of care



- Deprescibing at end-of-life



- Deprescribing anticoagulants



- Patient case #1



- Review of switching between anticoagulants



- Patient case #2



- Considering discontinuation


Instructor: Marisa Todd, PharmD, BCPS
As Director of Clinical Education at Enclara Pharmacia, Marisa is responsible for the coordination, integration, maintenance and advancement of Enclara Pharmacia’s education support services. Prior roles held by Marisa include manager of the West Deptford clinical call center, clinical pharmacist and new hire pharmacist trainer. She has 15 years of experience as a pharmacist in various fields including 11 years of hospice pharmacy experience, as well as clinical roles in both the hospital and home infusion settings. Throughout Marisa’s career, she has been continuously involved in the education and training of healthcare professionals and students. Marisa earned her doctor of pharmacy degree at Wilkes University, Nesbitt School of Pharmacy. She completed a 1-year post-graduate pharmacy practice residency program and maintains certification as a Board Certified Pharmacotherapy Specialist (BCPS). Disclosure: Marisa Todd, PharmD, BCPS has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Target Audience:
The target audience for this course is: Nurses; in the following settings: Hospice.
Relias will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Course Delivery Method and Format
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Accommodations
If you require special accommodations to complete this module, please contact Relias Customer Support here.